Article Information
History
- February 6, 2025.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Julián Peller, MSCS1,†,*,
- Marcos A Trevisan, PhD1,2,*,
- Gaston Bujia, MSc1,
- Felipe Aguirre1,
- Diego E. Shalom, PhD2,
- Alan Taitz, PhD3,
- Stephanie Henze1,
- Silviya Bastola1,
- Jason Osik, PhD4,
- Ryan A. Shewcraft, PhD4,
- Peng Jiang, PhD4,
- Joel Schwartz, PhD4,
- Terry Heiman-Patterson, MD5,
- Michael E. Sherman6,
- Matthew F. Wipperman, PhD, MSc7,
- Oren Levy, MD, PhD7,
- Guofa Shou, PhD8,
- Karl A. Sillay, MD1,
- Lyle W. Ostrow, MD, PhD5,
- Ernest Fraenkel, PhD9,
- James D. Berry, MD, MPH10,
- Indu Navar Bingham, MSCS1 and
- Esteban G. Roitberg, PhD1,11
- 1Peter Cohen Foundation dba Everything ALS, Seattle, Washington and Los Altos, California, USA
- 2Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Departamento de Física - CONICET – Universidad de Buenos Aires, Instituto de Física Interdisciplinaria y Aplicada (INFINA). Buenos Aires, Argentina
- 3SRI International, Menlo Park, CA, USA
- 4Bristol Myers Squibb, Cambridge, MA, USA
- 5Lewis Katz School of Medicine at Temple University, Department of Neurology, Philadelphia, PA, USA
- 6Department of Medicine, MCG-Hearst Health, Drexel University College of Medicine, Philadelphia, PA, USA
- 7Regeneron Pharmaceuticals, Tarrytown, NY, USA
- 8Eli Lilly and Company, Boston, MA, USA
- 9Massachusetts Institute of Technology, Department of Biological Engineering, Cambridge, MA, USA
- 10Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA
- 11Escuela de Ciencia y Tecnología, Universidad Nacional de San Martín, Buenos Aires, Argentina
- ↵†Corresponding author, Email: julian{at}everythingals.org.